| Primary |
| Hypertension |
60.0% |
| Product Used For Unknown Indication |
40.0% |
|
| Atrial Flutter |
33.3% |
| Hyponatraemia |
33.3% |
| Lichenoid Keratosis |
33.3% |
|
| Secondary |
| Hypertension |
44.8% |
| Drug Use For Unknown Indication |
21.8% |
| Product Used For Unknown Indication |
8.0% |
| Depression |
4.6% |
| Diabetes Mellitus |
2.3% |
| Metastatic Renal Cell Carcinoma |
2.3% |
| Arrhythmia |
1.1% |
| Arthritis |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Bone Disorder |
1.1% |
| Diverticulitis |
1.1% |
| Essential Hypertension |
1.1% |
| Gastritis |
1.1% |
| Generalised Non-convulsive Epilepsy |
1.1% |
| Obesity |
1.1% |
| Osteoporosis |
1.1% |
| Panic Disorder |
1.1% |
| Pulmonary Hypertension |
1.1% |
| Sedative Therapy |
1.1% |
| Sleep Disorder |
1.1% |
|
| Neck Pain |
12.0% |
| Oedema Peripheral |
12.0% |
| Renal Impairment |
8.0% |
| Cardiovascular Disorder |
4.0% |
| Diabetes Mellitus |
4.0% |
| Gingival Swelling |
4.0% |
| Glycosylated Haemoglobin Increased |
4.0% |
| Gout |
4.0% |
| Hypertension |
4.0% |
| Hyponatraemia |
4.0% |
| Lower Respiratory Tract Infection |
4.0% |
| Maculopathy |
4.0% |
| Myalgia |
4.0% |
| Panic Disorder |
4.0% |
| Renal Failure Acute |
4.0% |
| Rhabdomyolysis |
4.0% |
| Syncope |
4.0% |
| Throat Irritation |
4.0% |
| Toxic Epidermal Necrolysis |
4.0% |
| Tremor |
4.0% |
|
| Concomitant |
| Hypertension |
30.7% |
| Product Used For Unknown Indication |
15.7% |
| Drug Use For Unknown Indication |
10.8% |
| Rheumatoid Arthritis |
9.1% |
| Diabetes Mellitus |
8.1% |
| Blood Pressure |
3.2% |
| Type 2 Diabetes Mellitus |
2.4% |
| Cardiac Disorder |
2.0% |
| Pain |
2.0% |
| Breast Cancer |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Bone Disorder |
1.7% |
| Prophylaxis |
1.7% |
| Blood Cholesterol Abnormal |
1.4% |
| Lung Disorder |
1.4% |
| Osteoporosis |
1.4% |
| Anticoagulant Therapy |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Anxiety |
1.1% |
| Blood Cholesterol |
1.1% |
|
| Vomiting |
11.6% |
| Urinary Tract Infection |
10.5% |
| Weight Increased |
9.5% |
| Pneumocystis Jiroveci Pneumonia |
6.3% |
| Thrombosis |
6.3% |
| Nervousness |
4.2% |
| Oedema Peripheral |
4.2% |
| Pruritus |
4.2% |
| Pyrexia |
4.2% |
| Syncope |
4.2% |
| Throat Irritation |
4.2% |
| Total Lung Capacity Decreased |
4.2% |
| Traumatic Lung Injury |
4.2% |
| Death |
3.2% |
| Hyponatraemia |
3.2% |
| Loss Of Consciousness |
3.2% |
| Medication Error |
3.2% |
| Myocardial Infarction |
3.2% |
| Pain In Extremity |
3.2% |
| Pelvic Fracture |
3.2% |
|
